Article Text

Download PDFPDF
Dogs
Preoperative radiotherapy and acridine orange photodynamic therapy causing pneumocephalus in a dog
  1. Takuya Maruo1,
  2. Yuta Nishiyama2,
  3. Taiki Yokoyama2,
  4. Yuki Nemoto2 and
  5. Hideki Kayanuma1
  1. 1Laboratory of Veterinary Radiology, Department of Veterinary Medicine, Azabu University, Sagamihara, Japan
  2. 2Veterinary Teaching Hospital, Azabu University, Sagamihara, Japan
  1. Correspondence to Dr Takuya Maruo; maruo{at}azabu-u.ac.jp

Abstract

The authors present a rare case of treatment complications in a 12-year-old spayed female Shiba Inu with left nasal transitional cell carcinoma. To control the tumour, the authors performed hypofractionated radiotherapy for five fractions over 1 week, combined with surgery, acridine orange photodynamic therapy (AO-PDT) and cribriform irradiation, one month after the initial radiotherapy. Six months later, the dog presented with neurological abnormalities (circling, pacing and reduced consciousness). Pneumocephalus was diagnosed. The irradiated left side of the olfactory bulb had become necrotic; therefore, surgery was performed to close the hole of the cribriform plate. Two years later, no visible radiation side effects or clinical signs related to intranasal tumour recurrence were detected. This case suggests that hypofractionated radiotherapy followed by surgery, AO-PDT and cribriform irradiation can contribute to tumour control. However, rare side effects, such as pneumocephalus, should be considered. Therefore, patients should be monitored carefully for adverse events after this combination.

  • acridine orange photodynamic therapy
  • dogs
  • hypofractionated radiotherapy
  • pneumocephalus
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors TM was responsible for case management, TY for diagnostic imaging, HK for surgical correction, and both YNi and YNe for case follow-up. All wrote and corrected the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.